Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.
Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.
The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.
The 6th edition of the ENT Masterclass Cyber Textbook of Operative Surgery has been published and is completely free to access online. It is a carefully curated virtual library of surgical videos from leading experts across the globe. All sections...
Applications are open until 30 September 2023 to become a member of the World Hearing Forum. The global network is looking for people who want to advocate for hearing care and safe listening. The forum, which includes three working groups...
A week of events on the themes of hearing health, the sound environment and musical expression will take place in Edinburgh, Scotland, from 16 to 20 October 2023.